Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease

Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease

Secondary hyperparathyroidism (SHPT) relates to high turnover bone loss and is responsible for most bone fractures among chronic kidney disease (CKD) patients. Changes in the Wingless/beta-catenin signaling (Wnt/β-catenin) pathway and Wnt inhibitors have been found to play a critical role i...

Full description

Bibliographic Details
Main Authors:	Cai-Mei Zheng, Yung-Ho Hsu, Chia-Chao Wu, Chien-Lin Lu, Wen-Chih Liu, Jing-Quan Zheng, Yuh-Feng Lin, Hui-Wen Chiu, Tian-Jong Chang, Jia-Fwu Shyu, Kuo-Cheng Lu
Format:	Article
Language:	English
Published:	MDPI AG 2019-06-01
Series:	International Journal of Molecular Sciences
Subjects:	cinacalcet renal osteodystrophy osteoclast Wnt 10b chronic kidney disease
Online Access:	https://www.mdpi.com/1422-0067/20/11/2800

Similar Items

Calcitonin Induces Bone Formation by Increasing Expression of Wnt10b in Osteoclasts in Ovariectomy-Induced Osteoporotic Rats
by: Chen-Yuan Hsiao, et al.
Published: (2020-09-01)

Therapeutic Effect of Calcimimetics on Osteoclast–Osteoblast Crosslink in Chronic Kidney Disease and Mineral Bone Disease
by: Kuo-Chin Hung, et al.
Published: (2020-11-01)

Calciphylaxie, insuffisance rénale, cinacalcet
by: Fatima-Zahra Agharbi
Published: (2020-02-01)

Association of Anabolic Effect of Calcitriol with Osteoclast-Derived Wnt 10b Secretion
by: Chien-Lin Lu, et al.
Published: (2018-08-01)

CALCIFILAXIA URÉMICA SOB O EFEITO DO CALCIMIMÉTICO CINACALCET
by: Leonor Ramos, et al.
Published: (2015-04-01)

Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries
by: Douglas S. Fuller, et al.
Published: (2019-05-01)

A case of hyperparathyroidism-associated parkinsonism successfully treated with cinacalcet hydrochloride, a calcimimetic
by: Yuichiro Ohya, et al.
Published: (2018-05-01)

Cinacalcet versus parathyroidectomy for primary hyperparathyroidism: a single centre experienc
by: Salvatore Giovinazzo, et al.
Published: (2019-11-01)

Cinacalcet and primary hyperparathyroidism: systematic review and meta regression
by: Cheng Han Ng, et al.
Published: (2020-08-01)

Primary Hyperparathyroidism-A Review of this Disorder and an Interesting Case Treated with Cinacalcet
by: Abdul Rafi Mohammed, et al.
Published: (2009-06-01)

Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation
by: Soliman Amin R., et al.
Published: (2016-09-01)

Changes of Serum Total and Free Testosterone Concentrations in Male Chronic Hemodialysis Patients with Secondary Hyperparathyroidism in Response to Cinacalcet Treatment
by: Piotr Kuczera, et al.
Published: (2016-01-01)

Efficacy of low-dose cinacalcet on alternate days for the treatment of secondary hyperparathyroidism in hemodialysis patients: a single-center study
by: Gojaseni P, et al.
Published: (2017-02-01)

Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review
by: Michael Sheehan, et al.
Published: (2020-03-01)

WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M
by: Henning P, et al.
Published: (2021-09-01)

Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients
by: Chien-Te Lee, et al.
Published: (2013-04-01)

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
by: Jeong S, et al.
Published: (2016-07-01)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
by: Alessandro Roggeri, et al.
Published: (2020-03-01)

Effects of preoperative cinacalcet hydrochloride treatment on the operative course of parathyroidectomy and pathological changes in resected parathyroid glands
by: Akiko Takeshima, et al.
Published: (2017-10-01)

Use of Cinacalcet in the treatment of persistent hyperparathyroidism post-renal transplant. A single center experience in Argentina
by: Jorge Camacho, et al.
Published: (2017-06-01)

The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism
by: Paweena Susantitaphong, et al.
Published: (2019-01-01)

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
by: Giulia Di Dalmazi, et al.
Published: (2018-12-01)

Cinacalcet Treatment Significantly Improves All-Cause and Cardiovascular Survival in Dialysis Patients: Results from a Meta-Analysis
by: Yuan Zu, et al.
Published: (2019-11-01)

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
by: Ariadna Pérez-Ricart, et al.
Published: (2019-06-01)

PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET
by: R. I. Yagudina, et al.
Published: (2015-03-01)

PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET
by: L. V. Egshatyan, et al.
Published: (2015-09-01)

Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial
by: Yuka Kurokawa, et al.
Published: (2020-12-01)

Role of cinacalcet in the treatment of secondary hyperparathyroidism in chronic kidney disease
by: H.K. Aggarwal, et al.
Published: (2013-09-01)

Upregulating MicroRNA-410 or Downregulating Wnt-11 Increases Osteoblasts and Reduces Osteoclasts to Alleviate Osteonecrosis of the Femoral Head
by: Yukun Yin, et al.
Published: (2019-12-01)

Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
by: Keiichi Otsuka, et al.
Published: (2018-10-01)

A novel asymmetric synthesis of cinacalcet hydrochloride
by: Veera R. Arava, et al.
Published: (2012-08-01)

Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: results of a prospective randomized pilot study
by: Simone Brardi, et al.
Published: (2015-03-01)

Autophagy negative-regulating Wnt signaling enhanced inflammatory osteoclastogenesis from Pre-OCs in vitro
by: Lili Chen, et al.
Published: (2020-06-01)

Cinacalcet for Hypercalcemia Caused by Pulmonary Squamous Cell Carcinoma Producing Parathyroid Hormone-Related Peptide
by: Anneke Bech, et al.
Published: (2012-01-01)

Vitamin D-Resistant Rickets and Cinacalcet—One More Favorable Experience
by: Ramona C. Nicolescu, et al.
Published: (2018-11-01)

Diameter of Parathyroid Glands Measured by Computed Tomography as a Predictive Indicator for Response to Cinacalcet in Dialysis Patients with Secondary Hyperparathyroidism
by: Yu Ah Hong, et al.
Published: (2015-05-01)

Successful treatment of early allograft dysfunction with cinacalcet in a patient with nephrocalcinosis caused by severe hyperparathyroidism: a case report
by: Boonyarit Cheunsuchon, et al.
Published: (2017-04-01)

Inicial experience with cinacalcet in Argentina
by: Elisa Elena Del Valle, et al.
Published: (2015-01-01)

Roles of Wnt signaling in bone formation and resorption
by: Yasuhiro Kobayashi, et al.
Published: (2008-07-01)

Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison
by: Jacek Zawierucha, et al.
Published: (2019-02-01)

Cannot write session to /tmp/vufind_sessions/sess_5uhsa102476t29ld261j91j624